Stock Taper 
ASMB
$34.07
▼ DOWN 2.10% (-0.73)
KEY STATISTICS
Market Cap$675.17 M
52w High$39.71
52w Low$20.23
Dividend Yield—
Frequency—
P/E-309.73
Volume250.02K
Shares Out.19.82M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Jason A. Okazaki
COMPENSATION 2026
Salary$647,500
Stock Awards$661,671
Incentive Plan Pay$585,000
All Other Comp.$15,242
Total$2,482,987
ABOUT
SECTOR
Healthcare
WENT PUBLIC
December 17, 2010
METHOD OF GOING PUBLIC
Reverse Merger
FULL TIME EMPLOYEES
73
PRICE TARGET
Target High$50.00
Target Low$45.00
Target Median$47.50
Target Consensus$47.50
UPCOMING EARNINGS
DateNov 9, 2026
DayMonday
Rev. Est.$7.93M
NOV
9
MON
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2024-02-12 | Reverse | 1:12 |
| 2014-07-14 | Reverse | 1:5 |
PRICE
$34.07 ▼ DOWN 2.10% (−$0.73)About Assembly Biosciences, Inc.
https://www.assemblybio.com ↗Assembly Biosciences, a clinical-stage biotech based in South San Francisco, develops HBV therapies like Vebicorvir (Phase 2), ABI-H3733 (Phase 1a), and preclinical candidates, collaborating with partners including BeiGene and Arbutus.
INDUSTRY
Biotechnology
A PRODUCT ASSEMBLY BIOSCIENCES, INC. IS KNOWN FOR
ABI-4334
ABI-4334 is an oral, investigational capsid assembly modulator targeting chronic hepatitis B, demonstrating potent antiviral activity in Phase 1b, with the goal of achieving a functional cure for HBV.
Revenue by Products
| Icon | PRODUCT | Q2-2018 | Q3-2018 |
|---|---|---|---|
 | License and Service | $1.2M | $1.2M |
ETFS HOLDING THIS STOCK
ETFS HOLDING
46
LISTED HERE
10
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
60.67%
HOLDERS
103
TOP 12 OF 103 · RANKED BY POSITION SIZE
Gilead Sciences, Inc.
Farallon Capital Management LLC
Ra Capital Management, L.P.
Commodore Capital LP
Janus Henderson Group Plc
Paradigm Biocapital Advisors LP
Point72 Asset Management, L.P.
Vanguard Group Inc
Frazier Life Sciences Management, L.P.
Blackstone Inc.
Parkman Healthcare Partners LLC
Blackrock Institutional Trust Company, N.A.
RATINGS SNAPSHOT
Overall rating: C+
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book3
Overall Score2
TRADES BY CONGRESS
HOUSE TRADES
Chris Jacobs
Sale (Full)
2021-01-04
Christopher L. Jacobs
Purchase
2020-12-28
INSIDER TRADES
★
OFFICER: PFO AND PAO
Bjorkquist Jeanette M
Sale · 29 shares
2026-06-17
★
DIRECTOR
Johnson-Pratt Lisa
Purchase · 8.0K shares
2026-06-04
★
DIRECTOR
ALTIG ANTHONY E
Purchase · 8.0K shares
2026-06-04
★
OFFICER: PFO AND PAO
Bjorkquist Jeanette M
Purchase · 3.5K shares
2026-03-29
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 2
OUTPERFORM 1
3 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 ZURA | $5.72 | COMPARE |
 ARCT | $15.19 | COMPARE |
 ENTA | $13.60 | COMPARE |
 FHTX | $6.00 | COMPARE |
 SGMT | $10.55 | COMPARE |
 PYXS | $3.23 | COMPARE |
 IMRX | $4.99 | COMPARE |
 TNYA | $0.69 | COMPARE |